Evidence map›Paper›PMID 32458267›Full record

ArticleCanadian journal of anaesthesia = Journal canadien d'anesthesie2020

Therapeutic alternatives and strategies for drug conservation in the intensive care unit during times of drug shortage: a report of the Ontario COVID-19 ICU Drug Task Force.

Salmaan Kanji, Lisa Burry, David Williamson, Michelle Pittman, Samuel Dubinsky, Deep Patel, Sabrina Natarajan, Robert MacLean, Jin-Hyeun Huh, Damon C Scales and 2 more

Abstract read
In one paragraph

Article in Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Artificial intelligence in triage of COVID-19 patients.Frontiers in artificial intelligence · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Preparing for COVID-19-related Drug Shortages.Annals of the American Thoracic Society · 2020
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Salmaan KanjiDepartment of Pharmacy, The Ottawa Hospital, The Ottawa Hospital Research Institute, 501 Smyth Rd, Ottawa, ON, K1H 8L6, Canada. skanji@toh.ca.
Lisa BurryMount Sinai Hospital, Toronto, ON, Canada.
David WilliamsonSacré Coeur Hospital, Université de Montréal, Montreal, QC, Canada.
Michelle PittmanThe Ottawa Hospital, Ottawa, ON, Canada.
Samuel DubinskyThe Ottawa Hospital, Ottawa, ON, Canada.
Deep PatelThe Ottawa Hospital, Ottawa, ON, Canada.
Sabrina NatarajanThe Ottawa Hospital, Ottawa, ON, Canada.
Robert MacLeanThe Ottawa Hospital, Ottawa, ON, Canada.
Jin-Hyeun HuhUniversity Health Network, Toronto, ON, Canada.
Damon C ScalesInterdepartmental Division of Critical Care, University of Toronto, Toronto, ON, Canada.
David NeilipovitzThe Ottawa Hospital, Ottawa, ON, Canada.
Ontario COVID-19 ICU Drug Task Force (Appendix)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the coronavirus disease (COVID-19) global pandemic, urgent strategies to alleviate shortages are required. Evaluation of the feasibility, practicality, and value of drug conservation strategies and therapeutic alternatives requires a collaborative approach at the provincial level. The Ontario COVID-19 ICU Drug Task Force was directed to create recommendations suggesting drug conservation strategies and therapeutic alternatives for essential drugs at risk of shortage in the intensive care unit during the COVID-19 pandemic. Recommendations were rapidly developed using a modified Delphi method and evaluated on their ease of implementation, feasibility, and supportive evidence. This article describes the recommendations for drug conservation strategies and therapeutic alternatives for drugs at risk of shortage that are commonly used in the care of critically ill patients. Recommendations are identified as preferred and secondary ones that might be less desirable. Although the impetus for generating this document was the COVID-19 pandemic, recommendations should also be applicable for mitigating drug shortages outside of a pandemic. Proposed provincial strategies for drug conservation and therapeutic alternatives may not all be appropriate for every institution. Local implementation will require consultation from end-users and hospital administrators. Competing equipment shortages and available resources should be considered when evaluating the appropriateness of each strategy.

Indexed as

Intensive Care UnitsAdvisory CommitteesCoronavirus InfectionsCOVID-19COVID-19 Drug TreatmentCritical IllnessHumansOntarioPandemicsPharmaceutical PreparationsPneumonia, ViralPharmaceutical Preparationsconservation strategiesCOVID-19drug shortagepandemictherapeutic alternatives

Identifiers

PMID32458267
PMCPMC8297429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.